Uzunov P, Gnegy M, Lehne R, Revuelta A, Costa E
Adv Biochem Psychopharmacol. 1976;15:283-301.
This work supports the idea that PDEA is bound and stored in brain particulate fraction. The release of PDEA into cytosol where the activator-sensitive PDE is located, is the first event in the process of the regulation of cAMP metabolism and inactivation. PDEA is released by cAMP-dependent phosphorylation of the activator-binding sites. This process is Ca2+ independent and does not occur in the presence of cGMP and cGMP-dependent phosphorylation. The free, soluble PDEA activates the high Km PDE in the presence of micromolar concentrations of Ca2+. This protein decreases severalfold the Km for cAMP of the high Km activator-sensitive PDE. PDEA regulates cAMP metabolism when the concentration of cAMP is elevated by a transsynaptic activation of adenylate cyclase. The rate of synthesis and the release of PDEA might be a part of the process of receptor sub- and supersensitivity, which has been reported during denervation or as a result of chronic treatment with drugs.
这项研究支持了磷酸二酯酶 A(PDEA)与脑微粒体部分结合并储存的观点。PDEA 释放到激活剂敏感型磷酸二酯酶所在的细胞质溶胶中,是 cAMP 代谢调节和失活过程中的首个事件。PDEA 通过激活剂结合位点的 cAMP 依赖性磷酸化而释放。此过程不依赖 Ca2+,且在存在 cGMP 和 cGMP 依赖性磷酸化的情况下不会发生。游离的可溶性 PDEA 在微摩尔浓度的 Ca2+存在时激活高 Km 磷酸二酯酶。这种蛋白质使高 Km 激活剂敏感型磷酸二酯酶的 cAMP 的 Km 降低数倍。当腺苷酸环化酶通过跨突触激活使 cAMP 浓度升高时,PDEA 调节 cAMP 代谢。PDEA 的合成速率和释放可能是受体亚敏感性和超敏感性过程的一部分,这在去神经支配期间或药物长期治疗后已有报道。